34.98 USD
+0.77 (+2.25%)
At close: Feb 6, 2026
34.98 USD
0 (0%)
After Hours: 2/6/2026, 8:00:01 PM
Overall IBEX gets a fundamental rating of 7 out of 10. We evaluated IBEX against 87 industry peers in the IT Services industry. IBEX gets an excellent profitability rating and is at the same time showing great financial health properties. IBEX is evaluated to be cheap and growing strongly. This does not happen too often! This makes IBEX very considerable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
- In the past year IBEX was profitable.
- IBEX had a positive operating cash flow in the past year.
- In the past 5 years IBEX has always been profitable.
- In the past 5 years IBEX always reported a positive cash flow from operatings.
1.2 Ratios
- With an excellent Return On Assets value of 14.58%, IBEX belongs to the best of the industry, outperforming 93.10% of the companies in the same industry.
- The Return On Equity of IBEX (28.81%) is better than 89.66% of its industry peers.
- IBEX has a better Return On Invested Capital (21.63%) than 94.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.58% | ||
| ROE | 28.81% | ||
| ROIC | 21.63% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- IBEX has a better Profit Margin (7.14%) than 73.56% of its industry peers.
- In the last couple of years the Profit Margin of IBEX has grown nicely.
- Looking at the Operating Margin, with a value of 9.18%, IBEX is in the better half of the industry, outperforming 67.82% of the companies in the same industry.
- IBEX's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 30.62%, IBEX is in line with its industry, outperforming 42.53% of the companies in the same industry.
- IBEX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.18% | ||
| PM (TTM) | 7.14% | ||
| GM | 30.62% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBEX is creating value.
- IBEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- IBEX has an Altman-Z score of 5.15. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of IBEX (5.15) is better than 80.46% of its industry peers.
- The Debt to FCF ratio of IBEX is 0.05, which is an excellent value as it means it would take IBEX, only 0.05 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.05, IBEX belongs to the best of the industry, outperforming 93.10% of the companies in the same industry.
- IBEX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
- IBEX's Debt to Equity ratio of 0.01 is amongst the best of the industry. IBEX outperforms 83.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 5.15 |
ROIC/WACC2.27
WACC9.51%
2.3 Liquidity
- A Current Ratio of 1.82 indicates that IBEX should not have too much problems paying its short term obligations.
- IBEX has a Current ratio (1.82) which is comparable to the rest of the industry.
- A Quick Ratio of 1.82 indicates that IBEX should not have too much problems paying its short term obligations.
- With a Quick ratio value of 1.82, IBEX perfoms like the industry average, outperforming 56.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
- IBEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.77%, which is quite impressive.
- The Earnings Per Share has been growing by 41.04% on average over the past years. This is a very strong growth
- IBEX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.77%.
- The Revenue has been growing slightly by 6.62% on average over the past years.
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%
3.2 Future
- Based on estimates for the next years, IBEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.72% on average per year.
- The Revenue is expected to grow by 9.19% on average over the next years. This is quite good.
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 10.11, which indicates a very decent valuation of IBEX.
- 86.21% of the companies in the same industry are more expensive than IBEX, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of IBEX to the average of the S&P500 Index (27.93), we can say IBEX is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 9.66, the valuation of IBEX can be described as reasonable.
- Based on the Price/Forward Earnings ratio, IBEX is valued cheaply inside the industry as 86.21% of the companies are valued more expensively.
- When comparing the Price/Forward Earnings ratio of IBEX to the average of the S&P500 Index (27.77), we can say IBEX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.11 | ||
| Fwd PE | 9.66 |
4.2 Price Multiples
- 88.51% of the companies in the same industry are more expensive than IBEX, based on the Enterprise Value to EBITDA ratio.
- IBEX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IBEX is cheaper than 70.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.11 | ||
| EV/EBITDA | 6.38 |
4.3 Compensation for Growth
- IBEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of IBEX may justify a higher PE ratio.
- A more expensive valuation may be justified as IBEX's earnings are expected to grow with 13.72% in the coming years.
PEG (NY)0.44
PEG (5Y)0.25
EPS Next 2Y13.72%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- IBEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
34.98
+0.77 (+2.25%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)05-06 2026-05-06/amc
Inst Owners94.08%
Inst Owner Change-0.01%
Ins Owners2.8%
Ins Owner Change0.29%
Market Cap471.18M
Revenue(TTM)558.27M
Net Income(TTM)41.38M
Analysts45.71
Price Target41.82 (19.55%)
Short Float %0.81%
Short Ratio1.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.95%
Min EPS beat(2)20.05%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)16.83%
Min EPS beat(4)10.89%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)12.58%
EPS beat(12)10
Avg EPS beat(12)14.59%
EPS beat(16)12
Avg EPS beat(16)13.3%
Revenue beat(2)2
Avg Revenue beat(2)5.51%
Min Revenue beat(2)2.5%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.65%
Min Revenue beat(4)2.45%
Max Revenue beat(4)8.52%
Revenue beat(8)5
Avg Revenue beat(8)1.79%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)6.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.48%
EPS NY rev (1m)0%
EPS NY rev (3m)5.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.11 | ||
| Fwd PE | 9.66 | ||
| P/S | 0.81 | ||
| P/FCF | 15.11 | ||
| P/OCF | 8.79 | ||
| P/B | 3.28 | ||
| P/tB | 3.58 | ||
| EV/EBITDA | 6.38 |
EPS(TTM)3.46
EY9.89%
EPS(NY)3.62
Fwd EY10.35%
FCF(TTM)2.32
FCFY6.62%
OCF(TTM)3.98
OCFY11.37%
SpS43.04
BVpS10.66
TBVpS9.78
PEG (NY)0.44
PEG (5Y)0.25
Graham Number28.81
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.58% | ||
| ROE | 28.81% | ||
| ROCE | 26.64% | ||
| ROIC | 21.63% | ||
| ROICexc | 24.4% | ||
| ROICexgc | 26.15% | ||
| OM | 9.18% | ||
| PM (TTM) | 7.14% | ||
| GM | 30.62% | ||
| FCFM | 5.38% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 129.83% | ||
| Cap/Sales | 3.86% | ||
| Interest Coverage | 31.53 | ||
| Cash Conversion | 76.01% | ||
| Profit Quality | 75.39% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 5.15 |
F-Score8
WACC9.51%
ROIC/WACC2.27
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.48%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year68.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.26%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y19.11%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%
IBEX LTD / IBEX FAQ
Can you provide the ChartMill fundamental rating for IBEX LTD?
ChartMill assigns a fundamental rating of 7 / 10 to IBEX.
What is the valuation status for IBEX stock?
ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.
What is the profitability of IBEX stock?
IBEX LTD (IBEX) has a profitability rating of 7 / 10.
What is the valuation of IBEX LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for IBEX LTD (IBEX) is 10.11 and the Price/Book (PB) ratio is 3.28.
Is the dividend of IBEX LTD sustainable?
The dividend rating of IBEX LTD (IBEX) is 0 / 10 and the dividend payout ratio is 0%.